Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
HIV Medicine
|
March 31, 2011
Can antiretroviral therapy be safely interrupted and, if so, when?
E Lattuada, M Lanzafame, S Vento
Academic Radiology
|
January 16, 2026
Less Noise, More Confidence: Deep Learning Denoising Algorithm for Coronary Stenosis Assessment in pre-TAVI CT Imaging
Ludovica R M Lanzafame, Tommaso D'Angelo, Christian Booz
Lancet (London, England)
|
May 18, 2001
Clinical picture: tuberculous chorioretinitis
M Lanzafame, M Trevenzoli, S Vento, et al.
International Journal of STD & AIDS
|
March 3, 2007
Intracranial mass lesions in HIV/AIDS patients from developing countries endemic for neurocysticercosis
E Lattuada, M Lanzafame, E Concia, et al.
DNA Repair
|
November 26, 2009
Trichothiodystrophy: from basic mechanisms to clinical implications
M Stefanini, E Botta, M Lanzafame, et al.
HIV Medicine
|
March 6, 2012
Efavirenz dose reduction in HIV-infected patients
M Lanzafame, S Bonora, E Lattuada, et al.
Lancet (London, England)
|
August 25, 1999
Adherence to HAART in HIV
L Lazzarini, M Lanzafame, M Trevenzoli, et al.
Reproductive Biomedicine Online
|
December 22, 2009
Oxidative stress and medical antioxidant treatment in male infertility
Francesco M Lanzafame, Sandro La Vignera, Enzo Vicari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 5, 2000
Directly observed therapy in HIV therapy: A realistic perspective?
M Lanzafame, M Trevenzoli, A M Cattelan, et al.
Journal of Clinical Microbiology
|
February 24, 2001
Rhodotorula glutinis-related meningitis
M Lanzafame, G De Checchi, A Parinello, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
HIV Medicine
|
March 31, 2011
Can antiretroviral therapy be safely interrupted and, if so, when?
E Lattuada, M Lanzafame, S Vento
Academic Radiology
|
January 16, 2026
Less Noise, More Confidence: Deep Learning Denoising Algorithm for Coronary Stenosis Assessment in pre-TAVI CT Imaging
Ludovica R M Lanzafame, Tommaso D'Angelo, Christian Booz
Lancet (London, England)
|
May 18, 2001
Clinical picture: tuberculous chorioretinitis
M Lanzafame, M Trevenzoli, S Vento, et al.
International Journal of STD & AIDS
|
March 3, 2007
Intracranial mass lesions in HIV/AIDS patients from developing countries endemic for neurocysticercosis
E Lattuada, M Lanzafame, E Concia, et al.
DNA Repair
|
November 26, 2009
Trichothiodystrophy: from basic mechanisms to clinical implications
M Stefanini, E Botta, M Lanzafame, et al.
HIV Medicine
|
March 6, 2012
Efavirenz dose reduction in HIV-infected patients
M Lanzafame, S Bonora, E Lattuada, et al.
Lancet (London, England)
|
August 25, 1999
Adherence to HAART in HIV
L Lazzarini, M Lanzafame, M Trevenzoli, et al.
Reproductive Biomedicine Online
|
December 22, 2009
Oxidative stress and medical antioxidant treatment in male infertility
Francesco M Lanzafame, Sandro La Vignera, Enzo Vicari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 5, 2000
Directly observed therapy in HIV therapy: A realistic perspective?
M Lanzafame, M Trevenzoli, A M Cattelan, et al.
Journal of Clinical Microbiology
|
February 24, 2001
Rhodotorula glutinis-related meningitis
M Lanzafame, G De Checchi, A Parinello, et al.
Page
of 7